Comparative Studies Reveal Robust HbF Induction By Editing of HBG1/2 Promoters or BCL11A Erythroid-Enhancer in Human CD34+ Cells but That BCL11A Erythroid-Enhancer Editing Is Associated with Selective Reduction in Erythroid Lineage Reconstitution in a Xenotransplantation ModelKai‐Hsin Chang, Haiyan Jiang, Scott Haskett et al.|Blood|2018Cited by 9
Nonclinical evaluation of renizgamglogene autogedtemcel for SCD and TDTEugenio Marco, Kai‐Hsin Chang, Patricia Sousa et al.|Molecular Therapy|2025Cited by 3